Posts

Vinay Prasad's First Major Policy: Challenging Covid Vaccine 'Dogma' at FDA

on

Genentech Bets Again on Orionis With Potential $2B+ in Crowded Molecular Glue Space

on

Tourmaline Bio's Heart Drug Pacibekitug Shows Promise Against Cardiovascular Inflammation, Targets Competition with Novo, CSL

on

Pfizer Pays $1.25B Upfront to 3SBio, Joining the PD-1 x VEGF Race with Licensing Deal for SSGJ-707

on

CRISPR Therapeutics Partners with Sirius for siRNA Therapies, Expanding Beyond Gene Editing

on

Schrödinger Lays Off 60 Staffers Amid Economic Uncertainty

on

RegenXBio Secures Up to $250 Million by Monetizing Royalties from Zolgensma and Two Gene Therapies

on

Prime Medicine CEO Exits Amidst Layoffs and Restructuring as Sole Clinical Gene Therapy Shelved

on

SpyLock Technology: Recent News on Rapid Bispecific Antibody Screening

on

FDA Approves Novavax COVID Vaccine After Delay, Limits Use to Smaller High-Risk Population

on

Regeneron to Acquire 23andMe Out of Bankruptcy for $256 Million

on

Pfizer-backed CellCentric Secures $120M for Myeloma Drug Trials

on

Leqembi's Expansion and Blood Test Impact: Analyst Sees Gradual Uptake Boost

on